SI-BONE (NASDAQ:SIBN Shareholders Incur Further Losses as Stock Declines 8.8% This Week, Taking Three-year Losses to 33%
SI-BONE (NASDAQ:SIBN Shareholders Incur Further Losses as Stock Declines 8.8% This Week, Taking Three-year Losses to 33%
SI-BONE, Inc. (NASDAQ:SIBN) shareholders should be happy to see the share price up 14% in the last quarter. But that doesn't change the fact that the returns over the last three years have been less than pleasing. Truth be told the share price declined 33% in three years and that return, Dear Reader, falls short of what you could have got from passive investing with an index fund.
SI-BONE, Inc.(納斯達克股票代碼:SIBN)的股東應該很高興看到上個季度股價上漲14%。但這並不能改變這樣一個事實,即過去三年的回報並不令人滿意。說實話,股價在三年內下跌了33%,親愛的讀者,這一回報沒有達到指數基金被動投資所能獲得的回報。
If the past week is anything to go by, investor sentiment for SI-BONE isn't positive, so let's see if there's a mismatch between fundamentals and the share price.
如果說過去一週有意義的話,投資者對SI-BONE的情緒並不樂觀,所以讓我們看看基本面和股價之間是否存在不匹配的情況。
Because SI-BONE made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
由於SI-BONE在過去十二個月中出現虧損,我們認爲至少目前市場可能更加關注收入和收入增長。當一家公司沒有盈利時,我們通常希望看到良好的收入增長。可以想象,收入的快速增長如果持續下去,通常會帶來利潤的快速增長。
Over three years, SI-BONE grew revenue at 21% per year. That is faster than most pre-profit companies. The share price drop of 10% per year over three years would be considered disappointing by many, so you might argue the company is getting little credit for its impressive revenue growth. It's possible that the prior share price assumed unrealistically high future growth. Still, with high hopes now tempered, now might prove to be an opportunity to buy.
在過去的三年中,SI-BONE的收入以每年21%的速度增長。這比大多數盈利前公司要快。許多人會認爲三年內股價每年下跌10%,令人失望,因此你可能會爭辯說,該公司令人印象深刻的收入增長几乎沒有得到任何讚譽。之前的股價可能假設未來的高增長率是不切實際的。儘管如此,現在寄予厚望的希望有所減弱,現在可能是一個買入的機會。
The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).
公司的收入和收益(隨着時間的推移)如下圖所示(點擊查看確切數字)。
Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.
資產負債表的強度至關重要。可能值得一看我們關於其財務狀況如何隨着時間的推移而變化的免費報告。
A Different Perspective
不同的視角
SI-BONE shareholders are down 27% for the year, but the market itself is up 21%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 4% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 3 warning signs for SI-BONE that you should be aware of.
SI-BONE的股東今年下跌了27%,但市場本身上漲了21%。但是,請記住,即使是最好的股票有時也會在十二個月內表現不如市場。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨4%的總虧損。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。例如,我們已經確定了 SI-BONE 的 3 個警告信號,你應該注意這些信號。
Of course SI-BONE may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
當然,SI-BONE可能不是最好的買入股票。因此,您可能希望看到這批免費的成長股。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。